Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 651–653 of 653 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04662294	CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases	recruiting	Early Phase 1	108	Zhejiang UniversityOTHER	1	Nov 4, 2021	clinicaltrials
NCT05025098	Precision Therapy Versus Standard Therapy in AML and MDS in Elderly(PALM)	recruiting	Phase 2	36	University Hospital, AkershusOTHER	1	Aug 27, 2021	clinicaltrials